Inia, Michelle Love C.
HRN: 14-11-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2023
CEFUROXIME 1.5GM (VIAL)
10/05/2023
10/05/2023
IV
1.5 G
Once PTOR
For Elective CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes